Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
Manufactured by
Seoul, South Korea
The first mover as a Real-time PCR Company for Molecular Diagnostics. Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R D works and testing service for Human, Food and Animal. We have put major efforts in searching a new market, and new R D works of the genetic analysis, so we have been successful at expanding the base ofReal-time PCR technique in clinical diagnostics area. As a result, KogeneBiotech is the Korean industry leader in the field of PCR/Real-time PCR Kit market for a human molecular diagnostics, food genetic analysis and animal disease. We continues to grow by contributing to the popularization of MDx around the world.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Genesystem Co., Ltd.
South Korea · 1 relevant product
Applied Biocode, Inc.
United States · 2 relevant products
APPOLON BIOTECK SAS
France · 2 relevant products
Goldsite Diagnostics Inc.
China · 2 relevant products
FlashDx Inc.
United States · 1 relevant product
Operon S.A.
Spain · 2 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 3 relevant products
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 1 relevant product
Vitrosens Biyoteknoloji Anonim Sirketi
Türkiye · 1 relevant product
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 114 closest product alternatives
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Genesystem Co., Ltd. · South Korea
Multiplex molecular diagnostic test for simultaneous detection of SARS-CoV-2, influenza, and respiratory syncytial virus. Provides rapid and precise results using biochip-based technology.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
APPOLON BIOTECK SAS · France
Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.
Goldsite Diagnostics Inc. · China
Multiplex antigen test simultaneously detecting SARS-CoV-2, Influenza A/B, and RSV from a single patient sample. Enables rapid point-of-care diagnosis of common respiratory pathogens for clinical and emergency settings.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplex rapid antigen detection test that simultaneously identifies Influenza A, Influenza B, and SARS-CoV-2 from a single sample. This combo test provides comprehensive respiratory pathogen screening at the point of care.
FlashDx Inc. · United States
Rapid molecular diagnostic test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV using sample-to-answer syndromic testing technology. Enables near-patient testing with fast turnaround for respiratory pathogen identification, supporting clinical decision-making and patient management in healthcare settings.
Operon S.A. · Spain
A molecular diagnostic test for the simultaneous detection of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus in human samples. Used for in vitro diagnosis of respiratory infections.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.
Vitrosens Biyoteknoloji Anonim Sirketi · Türkiye
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2, influenza A/B, RSV, adenovirus, and human metapneumovirus from respiratory specimens. Delivers results in 5–10 minutes using immunofluorescence or rapid immunochromatographic methods, enabling point-of-care screening and differential diagnosis of respiratory infections.
102 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products